Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Scribe Therapeutics Inc. (SCTX)

15.42 -2.02 (-11.58%)
At close: October 30 at 4:00:00 PM EDT
15.57 +0.15 (+0.97%)
Overnight: 8:05:44 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
Total Revenue
33,302
51,174
27,413
Operating Expense
64,008
77,244
70,242
Operating Income
-30,706
-26,070
-42,829
Net Non Operating Interest Income Expense
209
933
3,773
Other Income Expense
-2,141
1,527
1,495
Pretax Income
-32,638
-23,610
-37,561
Tax Provision
-334
-1,802
10,225
Net Income Common Stockholders
-32,304
-21,808
-47,786
Diluted NI Available to Com Stockholders
-32,304
-21,808
-47,786
Basic EPS
-1.84
--
--
Diluted EPS
-1.84
--
--
Basic Average Shares
16,182.01
--
--
Diluted Average Shares
16,182.01
--
--
Total Operating Income as Reported
-30,706
-26,070
-42,829
Total Expenses
64,008
77,244
70,242
Net Income from Continuing & Discontinued Operation
-32,304
-21,808
-47,786
Normalized Income
-32,304
-21,808
-47,786
Interest Income
2,280
3,326
6,154
Interest Expense
2,071
2,393
2,381
Net Interest Income
209
933
3,773
EBIT
-30,567
-21,217
-35,180
EBITDA
-27,630
-18,140
-32,291
Reconciled Depreciation
2,937
3,077
2,889
Net Income from Continuing Operation Net Minority Interest
-32,304
-21,808
-47,786
Normalized EBITDA
-27,630
-18,140
-32,291
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2024 - 7/27/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: